In this episode, Drs. Christie Ballantyne and Eugenia Gianos discuss updates regarding the management of dyslipidemia released in new guidelines from the ACC and AHA Joint Committee on Clinical Practical Guidelines. Drs. Ballantyne and Gianos highlight the risks associated with high LDL-C levels and recent developments in clinical guidelines for patients who meet specific criteria for diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) and heterozygous familial hypercholesterolemia (HeFH). Up-to-date therapies are explored in depth.

To visit the course page for the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment, click here!